You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雙鷺藥業(002038.SZ)逆勢收漲4.09% 含CBD國產非特殊用途化粧品備案獲通過
格隆匯 09-09 15:03
格隆匯9月9日丨雙鷺藥業(002038.SZ)逆勢收漲4.09%報12.98元,成交3.45億元,最新總市值133億元。該股早盤一度衝高8%。公司昨晚公告,控股子公司海布生物含大麻葉提取物CBD的“國產非特殊用途化粧品備案(首次備案)”已獲雲南省藥品監督管理局審批通過。雙鷺藥業表示,目前海布生物已獲得工業大麻種植和生產許可,今年已完成3000畝的試種,計劃於10月底前收穫及進行CBD生產提取,其綜合利用計劃也將隨後展開;與此同時,海布生物計劃明年擴大種植面積和加工規模。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account